- Home
- SCM vs ABSI Comparison
SCM vs ABSI Comparison
Compare SCM & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCM
- ABSI
- Stock Information
- Founded
- SCM 2012
- ABSI 2011
- Country
- SCM United States
- ABSI United States
- Employees
- SCM N/A
- ABSI N/A
- Industry
- SCM Finance/Investors Services
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- SCM Finance
- ABSI Health Care
- Exchange
- SCM Nasdaq
- ABSI Nasdaq
- Market Cap
- SCM 392.4M
- ABSI 338.0M
- IPO Year
- SCM 2012
- ABSI 2021
- Fundamental
- Price
- SCM $13.73
- ABSI $2.79
- Analyst Decision
- SCM Hold
- ABSI Strong Buy
- Analyst Count
- SCM 1
- ABSI 5
- Target Price
- SCM $13.00
- ABSI $8.40
- AVG Volume (30 Days)
- SCM 113.5K
- ABSI 2.9M
- Earning Date
- SCM 08-06-2025
- ABSI 08-13-2025
- Dividend Yield
- SCM 11.63%
- ABSI N/A
- EPS Growth
- SCM 26.74
- ABSI N/A
- EPS
- SCM 1.42
- ABSI N/A
- Revenue
- SCM $103,691,042.00
- ABSI $4,815,000.00
- Revenue This Year
- SCM $1.85
- ABSI $81.76
- Revenue Next Year
- SCM $2.30
- ABSI $287.79
- P/E Ratio
- SCM $9.66
- ABSI N/A
- Revenue Growth
- SCM N/A
- ABSI N/A
- 52 Week Low
- SCM $11.19
- ABSI $2.01
- 52 Week High
- SCM $15.56
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- SCM 58.77
- ABSI 47.46
- Support Level
- SCM $13.49
- ABSI $2.65
- Resistance Level
- SCM $13.80
- ABSI $2.87
- Average True Range (ATR)
- SCM 0.23
- ABSI 0.19
- MACD
- SCM 0.03
- ABSI -0.01
- Stochastic Oscillator
- SCM 84.62
- ABSI 24.03
About SCM Stellus Capital Investment Corporation
Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.